Page 224 - Medicinal Chemistry Self Assessment
P. 224

Chapter 1.23
                Please replace the structure for Question 2 in Chapter 1.23 with the one shown below.  (NOTE:  The analogous
                structure in Chapter 2.23 is fine.)





                                                                                              2.23  Quinapril      213

                Chapters 1.23 and 2.23
                 4.  Quinapril inhibits ACE. This enzyme is a relatively nonspecific dipeptidyl carboxypeptidase. It is a zinc
                Please replace the structures for Angiotensin I and Quinaprilat in Question 4 for both 1.23 and 2.23 with the
                    protease that converts angiotensin I, a decapeptide, to angiotensin II, an octapeptide. The peptide  one
                    cleavage is catalyzed by the zinc atom and is shown below. Quinapril, along with other ACE inhibi-
                provided below.
                 4.  Quinapril inhibits ACE. binding interactions are occurring at a pH of 7.4.
                    tors, is a tripeptide mimic that can interact with the enzyme resulting in enzyme inhibition rather

                    than hydrolysis. Using this information and the structures provided below, identify how quinapril can
                    interact with ACE. Assume that all drug binding interactions are occurring at a pH=7.4.

                                                      Leu
                                                      Leu








                     Phe                         His
                     Phe                          His                            Quinaprilat
                               Angiotensin I                                      Quinaprilat
                         R = Asp-Arg-Val-Tyr-Ile-His
                                 Angiotensin I
                         R = Asp-Arg-Val-Tyr-Ile-His-Pro

                     Answer
                    Answer


                                                      D
                                                                                 B

                                                                      C



                                           E



                                                                                  A


                    Because ACE is a nonspecific dipeptidyl carboxypeptidase, it is able to hydrolyze a dipeptide sequence
                    from the carboxylic acid end of a peptide. For this enzyme to be able to cleave a dipeptide sequence
                    (i.e., two amino acids), substrates must have a minimum length of three amino acids. Quinaprilat and

                    other ACE inhibitors act as tripeptide mimics. These drug molecules retain key peptide features (i.e.,
                    peptide bonds, side chains similar to those found on amino acids), but are not able to be hydrolyzed.
                    Thus, they are able to interact in a similar manner as the substrate does. The table below lists five key
                    interactions of quinaprilat with ACE.

                               Drug Binding
                               Interaction               Explanation
                     A         Ionic interaction         This carboxylic acid mimics the C-terminal carboxylic acid of an ACE substrate and
                                                         will participate in an ionic interaction with the side chain of either Asp or Glu.
                     B         van der Waals and/or hydrophobic   Because ACE is a nonspecific carboxypeptidase, quinapril does not need to exactly
                               binding with hydrophobic amino   mimic Leu, the C-terminal amino acid of angiotensin I. Similar to the side chain of
                               acids (e.g., Phe, Tyr, Leu, Ile)  Leu, this ring system is hydrophobic and can participate in similar types of interac-
                                                         tions as Leu.
   219   220   221   222   223   224   225   226   227   228   229